Everest Medicines (HKSE:01952) Other Operating Expense : HK$-19.2 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Everest Medicines Other Operating Expense?

Everest Medicines's Other Operating Expense for the six months ended in Jun. 2024 was HK$-7.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-19.2 Mil.

Everest Medicines's quarterly Other Operating Expense declined from Jun. 2023 (HK$-2.4 Mil) to Dec. 2023 (HK$-12.0 Mil) but then increased from Dec. 2023 (HK$-12.0 Mil) to Jun. 2024 (HK$-7.2 Mil).

Everest Medicines's annual Other Operating Expense increased from Dec. 2021 (HK$-6.1 Mil) to Dec. 2022 (HK$-5.2 Mil) but then declined from Dec. 2022 (HK$-5.2 Mil) to Dec. 2023 (HK$-14.4 Mil).

Everest Medicines Other Operating Expense Historical Data

The historical data trend for Everest Medicines's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Everest Medicines Other Operating Expense Chart

Everest Medicines Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-6.91

-1.28

-6.07

-5.16

-14.41

Everest Medicines Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Operating Expense	Get a 7-Day Free Trial						-1.21	-4.01	-2.42	-11.99	-7.24

Everest Medicines Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-19.2 Mil.

Everest Medicines Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Everest Medicines's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Everest Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Everest Medicines Ltd (HKSE:01952) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

6HN:Germany

Address

1168 West Nanjing Road, 16th Floor, CITIC Pacific Plaza, Jing’an District, Shanghai, CHN, 200041

Website

https://www.everestmedicines.com

Everest Medicines Ltd is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of potentially novel or differentiated therapies and vaccines to address critical unmet medical needs initially in the Asia Pacific markets and eventually around the world. Its product pipeline includes; Nefecon (TarpeyoTM), EVER001 (previously known as XNW1011), PTX-COVID19-B, Eravacycline (Xerava), EVER206 (also known as SPR206), and others.

Executives

Fu Wei	2307 Founder of a discretionary trust who can infl
Nova Aqua Limited	2201 Interest of corporation controlled by you
C-bridge Joint Value Creation Limited	2201 Interest of corporation controlled by you
Everest Management Holding Co., Ltd.	2101 Beneficial owner
Ra Capital Management, L.p.	2102 Investment manager
Kolchinsky Peter	2305 Beneficiary of a trust
Kolchinsky Anna Inge Leonore Haas	2202 Interest of your spouse
Ra Capital Healthcare Fund, L.p.	2101 Beneficial owner
Ra Capital Healthcare Fund Gp, Llc	2201 Interest of corporation controlled by you
Fu Wei	2307 Founder of a discretionary trust who can infl
Janchor Partners Limited	2102 Investment manager
C-bridge Capital Gp, Ltd.	2501 Other
Vistra Trust (singapore) Pte. Limited	2501 Other
C-bridge Capital Gp Iv, Ltd.	2201 Interest of corporation controlled by you
C-bridge Iv Investment Nine Limited	2101 Beneficial owner

Everest Medicines Headlines

No Headlines